Literature DB >> 1938684

Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin.

I M Gould1, K Milne, G Harvey, C Jason.   

Abstract

Ionic binding, post-antibiotic effect (PAE) and adaptive resistance to netilmicin and ciprofloxacin were investigated in 11 distinct clinical isolates. Both netilmicin and ciprofloxacin showed concentration dependent kill and PAE when bacteria were exposed to these antibiotics at 37 degrees C. The effects of netilmicin were maintained at 4 degrees C, when there is no energy dependent cell uptake of antibiotic, but were partially inhibited by exposure to NaCl and EDTA although not by Ca++. This supports the concept that ionic binding to the bacterial cell wall is important in the initial uptake of netilmicin. Ciprofloxacin showed no such effects at 4 degrees C. Adaptive resistance (reduced bacterial kill on second exposure) occurred with both netilmicin and ciprofloxacin but was seen more frequently with netilmicin. It persisted longer than classical PAE but, even after continuous exposure, was not enough to suggest a loss of kill with a twice daily dosing regimen of netilmicin or ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938684     DOI: 10.1093/jac/27.6.741

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.

Authors:  Nicolas Grégoire; Sophie Raherison; Claire Grignon; Emmanuelle Comets; Manuella Marliat; Marie-Cécile Ploy; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

3.  Modeling the Emergence of Antibiotic Resistance in the Environment: an Analytical Solution for the Minimum Selection Concentration.

Authors:  Ben K Greenfield; Shanna Shaked; Carl F Marrs; Patrick Nelson; Ian Raxter; Chuanwu Xi; Thomas E McKone; Olivier Jolliet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.

Authors:  J A Karlowsky; G G Zhanel; R J Davidson; S R Zieroth; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 5.  Aminoglycoside adaptive resistance: importance for effective dosage regimens.

Authors:  M L Barclay; E J Begg
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.

Authors:  J A Karlowsky; M H Saunders; G A Harding; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

7.  Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.

Authors:  Michelle D Brazas; Elena B M Breidenstein; Joerg Overhage; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

8.  Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.

Authors:  J A Karlowsky; G G Zhanel; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

9.  Protein binding and serum bactericidal activities of vancomycin and teicoplanin.

Authors:  R S Dykhuizen; G Harvey; N Stephenson; D Nathwani; I M Gould
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.

Authors:  David A Butler; Amisha P Rana; Fiorella Krapp; Shitalben R Patel; Yanqin Huang; Egon A Ozer; Alan R Hauser; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2021-02-11       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.